跳至主要内容
临床试验/NCT02254382
NCT02254382终止不适用

Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure

ResMed4 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
ResMed
入组人数
2
试验地点
4
主要终点
Change in Apnea-Hypopnea-Index (AHI)

研究概览

简要总结

This is a multicenter, prospective, randomized clinical trial (pilot study). 20 participants with diastolic heart failure will be assigned to ventilation therapy (AutoSet CS ™ ASV device; therapy group). The trial will run for 6 months, after which change in echocardiographic parameters of diastolic left ventricular function, sleep and quality of life parameters will be evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical signs and symptoms of heart failure according to the ESC guidelines
  • Echocardiographic evidence of a preserved systolic left ventricular function (echocardiographic left ventricular ejection fraction > 50%)
  • Polysomnographic evidence of at least moderate sleep-disordered breathing: apnea-hypopnea index (AHI) > 15 / h with ≥ 50% central events and with with a central AHI of ≥ 10/h (AHI based on total sleeping time, TST)
  • BNP or NT-pro BNP ≥ 300 pg / ml
  • NYHA class II or III
  • Patient tolerates the ventilation treatment (1h sample ventilation)
  • Stable drug therapy in the last 4 weeks prior to randomization (no iv diuretic therapy or increasing the dose of diuretics to ≥ 100%)
  • Minimum age of patients of 18 years
  • patient willing to undergo study procedures
  • signed informed consent

排除标准

  • Oxygen saturation (sO2) <92% of the days in peace without O2 therapy, measured baseline (start time) in the pulse oximetry or polysomnography in a cape. BGA (the measurement must be max. Lie back 1 week)
  • Patients, who have a risk professional with symptomatic sleep apnea
  • Known COPD with FEV1 <70%
  • patients with NYHA stadium IV
  • Advanced congenital heart defects
  • pericardial diseases
  • Existing PAP or bi-level therapy (including adaptive servo-ventilation) in the last 3 months
  • Acute cardiac event in the last 3 months
  • BMI ≥ 35kg / m²
  • Pregnant or lactating women

结局指标

主要结局

Change in Apnea-Hypopnea-Index (AHI)

时间窗: 6 months

次要结局

  • Change of nocturia(6 months)
  • Change of galactin-3(6 months)
  • Changes in spiroergometry data (substudy)(6 months)
  • Change of echocardiographic parameters of diastolic function(6 months)
  • Changes of questionnaires: ESS(6 months)
  • Change of echocardiographic parameter of diastolic left ventricular ejection fraction function E/è(6 months)
  • Change of NYHA stage(6 months)
  • Change in total sleeping time (TST) determined by parameters of polysomnography(6 months)
  • Change in sleep quality determined by parameters of polysomnography(6 months)
  • Change in sleep efficacy determined by parameters of polysomnography(6 months)
  • Change in 6 minute walk test (MWT)(6 months)
  • Change in morning heart rate(6 months)
  • Changes in parameters of cardiac repolarisation (QT(c), TpTe(c) intervals, TpTe/QT ratio) in ECG at rest(6 months)
  • Analysis of compliance data(6 months)
  • Changes of questionnaires: MLHFQ(6 months)
  • Changes of questionnaires (PHQ9)(6 months)
  • Changes of questionnaires (SF12HSQ)(6 months)
  • Change in NT-pro BNP and BNP(6 months)
  • Changes in blood gas analysis(6 months)
  • Hospitalisations (reason)(6 months)
  • Change in morning blood pressure(6 months)
  • Occurrence of Adverse Events (AE) and Serious Adverse Events (SAE)(6 months)
  • Changes in occurrence of ventricular and supraventricular arrhythmias (PSG-ECG)(6 months)
  • Hospitalisations (cumulative length)(6 months)

研究者

发起方
ResMed
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验